Inventor · disambiguated record
Peter Hongaard Andersen
Also filed as: ANDERSEN PETER · ANDERSEN PETER H · ANDERSEN PETER HONGAARD
19 granted patents·7 pending applications·112 citations·filing 1986–2024
94Inventor score
Top patents by PatentIndex Score
26 records- 0191US10118907B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2017·Granted Nov 6, 2018·5 cites·9 claims
- 0291US9012453B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaLUNDBECK & CO AS H·Filed 2013·Granted Apr 21, 2015·9 cites·28 claims
- 0390US10501427B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2018·Granted Dec 10, 2019·4 cites·6 claims
- 0490US9617231B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2015·Granted Apr 11, 2017·5 cites·3 claims
- 0590US9216961B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaLUNDBECK & CO AS H·Filed 2015·Granted Dec 22, 2015·5 cites·11 claims
- 0689US11059798B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2019·Granted Jul 13, 2021·3 cites·9 claims
- 0789US2025250244A1Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 0887US11065257B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2017·Granted Jul 20, 2021·3 cites·9 claims
- 0986US8575174B2Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophreniaJORGENSEN MORTEN·Filed 2012·Granted Nov 5, 2013·9 cites·30 claims
- 1082US10906915B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 1181US11299497B2Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitorsUNION THERAPEUTICS AS·Filed 2018·Granted Apr 12, 2022·2 cites·12 claims
- 1277US12116355B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2021·Granted Oct 15, 2024·0 cites·7 claims
- 1377US5990084ACompounds with growth hormone releasing propertiesNOVO NORDISK AS·Filed 1997·Granted Nov 23, 1999·44 cites·77 claims
- 1476US11377425B1Small molecule modulators of IL-17LEO PHARMA AS·Filed 2019·Granted Jul 5, 2022·1 cites·73 claims
- 1562US2022362259A1Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2021·Application pending·0 cites
- 1659US4751222A2,3,4,5-tetrahydro-1H-3-benzazepines and CNS affecting use thereofNOVO INDUSTRI AS·Filed 1986·Granted Jun 14, 1988·10 cites·13 claims
- 1759US2025197378A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2023·Application pending·0 cites
- 1851US2023227435A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2021·Application pending·0 cites
- 1950US2009143435A1GABA enhancers in the treatment of diseases relating to reduced neurosteroid activityLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 2046US2022162191A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2020·Application pending·0 cites
- 2144US5010074ANovel benzazepine derivativesNOVO NORDISK AS·Filed 1989·Granted Apr 23, 1991·3 cites·30 claims
- 2242US2004024038A1GABA enhancers in the treatment of diseases relating to reduced neurosteroid activityLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 2339US5126363AIndole derivatives and their useNOVO NORDISK AS·Filed 1991·Granted Jun 30, 1992·3 cites·6 claims
- 2435US5250538AIndole derivatives and their useNOVO NORDISK AS·Filed 1992·Granted Oct 5, 1993·1 cites·10 claims
- 2533US5227488AAza spiro decane and use thereof in treating cns disordersNOVO NORDISK AS·Filed 1990·Granted Jul 13, 1993·1 cites·7 claims
- 2631US5025009ANovel benzazepine derivativesNOVO NORDISK AS·Filed 1990·Granted Jun 18, 1991·1 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →